For the third time in a year and a half, disappointing clinical trials from Bristol-Myers Squibb has sunk their stock.
Here is an analysis of what is occurring in the stock and the outlook for trades shortly.
This Bristol-Myers Squibb Stock article is for FullyInformed Members.
Bristol-Myers Squibb Stock – June 4 2018
Internal Stock and Option Trades Links
Portfolio Listing by Years
My Principal Stocks Index
Trade Ideas for Members
Trade Alerts for Members
Put Selling Strategies
Put Selling Strategies For Members
Covered Calls Strategies
Covered Calls Strategies For Members
Profit And Income Strategies Index
Stock and Option Strategies For Members
Stock And Option Trades Explained For Members
Ask A Question About A Trade You Are In
Sign My Guestbook
Visit My Shop
Join The Free Options Forum